5-(3-methoxy-4-methylphenyl)-3-(3-methyl-4-pyridinyl)-1,2,4-oxadiazole;5-(3-methoxy-4-methylphenyl)-3-(5-methyl-3-pyridinyl)-1,2,4-oxadiazole;4-[5-(3-methoxy-4-methylphenyl)-1,2,4-oxadiazol-3-yl]pyridin-2-amine;5-(3-methoxy-4-methylphenyl)-3-pyridin-3-yl-1,2,4-oxadiazole;3-(3-methyl-4-pyridinyl)-5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(5-methyl-3-pyridinyl)-5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;4-[5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]pyridin-2-amine;5-[4-methyl-3-(trifluoromethyl)phenyl]-3-pyridin-3-yl-1,2,4-oxadiazole;5-(4-octylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole

C145H127F12N29O13 — CID 157417571

IUPAC5-(3-methoxy-4-methylphenyl)-3-(3-methyl-4-pyridinyl)-1,2,4-oxadiazole;5-(3-methoxy-4-methylphenyl)-3-(5-methyl-3-pyridinyl)-1,2,4-oxadiazole;4-[5-(3-methoxy-4-methylphenyl)-1,2,4-oxadiazol-3-yl]pyridin-2-amine;5-(3-methoxy-4-methylphenyl)-3-pyridin-3-yl-1,2,4-oxadiazole;3-(3-methyl-4-pyridinyl)-5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(5-methyl-3-pyridinyl)-5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;4-[5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]pyridin-2-amine;5-[4-methyl-3-(trifluoromethyl)phenyl]-3-pyridin-3-yl-1,2,4-oxadiazole;5-(4-octylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole
SMILESCCCCCCCCc1ccc(-c2nc(-c3ccncc3)no2)cc1.COc1cc(-c2nc(-c3cccnc3)no2)ccc1C.COc1cc(-c2nc(-c3ccnc(N)c3)no2)ccc1C.COc1cc(-c2nc(-c3ccncc3C)no2)ccc1C.COc1cc(-c2nc(-c3cncc(C)c3)no2)ccc1C.Cc1ccc(-c2nc(-c3cccnc3)no2)cc1C(F)(F)F.Cc1ccc(-c2nc(-c3ccnc(N)c3)no2)cc1C(F)(F)F.Cc1cncc(-c2noc(-c3ccc(C)c(C(F)(F)F)c3)n2)c1.Cc1cnccc1-c1noc(-c2ccc(C)c(C(F)(F)F)c2)n1
InChIInChI=1S/C21H25N3O.2C16H12F3N3O.2C16H15N3O2.C15H11F3N4O.C15H10F3N3O.C15H14N4O2.C15H13N3O2/c1-2-3-4-5-6-7-8-17-9-11-19(12-10-17)21-23-20(24-25-21)18-13-15-22-16-14-18;1-9-5-12(8-20-7-9)14-21-15(23-22-14)11-4-3-10(2)13(6-11)16(17,18)19;1-9-3-4-11(7-13(9)16(17,18)19)15-21-14(22-23-15)12-5-6-20-8-10(12)2;1-10-6-13(9-17-8-10)15-18-16(21-19-15)12-5-4-11(2)14(7-12)20-3;1-10-4-5-12(8-14(10)20-3)16-18-15(19-21-16)13-6-7-17-9-11(13)2;1-8-2-3-10(6-11(8)15(16,17)18)14-21-13(22-23-14)9-4-5-20-12(19)7-9;1-9-4-5-10(7-12(9)15(16,17)18)14-20-13(21-22-14)11-3-2-6-19-8-11;1-9-3-4-11(7-12(9)20-2)15-18-14(19-21-15)10-5-6-17-13(16)8-10;1-10-5-6-11(8-13(10)19-2)15-17-14(18-20-15)12-4-3-7-16-9-12/h9-16H,2-8H2,1H3;2*3-8H,1-2H3;2*4-9H,1-3H3;2-7H,1H3,(H2,19,20);2-8H,1H3;3-8H,1-2H3,(H2,16,17);3-9H,1-2H3
InChIKeyBPAMBTMYSBCDIP-UHFFFAOYSA-N
MW2711.78 g/mol
LogP35.07
Rot. Bonds29

About 5-(3-methoxy-4-methylphenyl)-3-(3-methyl-4-pyridinyl)-1,2,4-oxadiazole;5-(3-methoxy-4-methylphenyl)-3-(5-methyl-3-pyridinyl)-1,2,4-oxadiazole;4-[5-(3-methoxy-4-methylphenyl)-1,2,4-oxadiazol-3-yl]pyridin-2-amine;5-(3-methoxy-4-methylphenyl)-3-pyridin-3-yl-1,2,4-oxadiazole;3-(3-methyl-4-pyridinyl)-5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(5-methyl-3-pyridinyl)-5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;4-[5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]pyridin-2-amine;5-[4-methyl-3-(trifluoromethyl)phenyl]-3-pyridin-3-yl-1,2,4-oxadiazole;5-(4-octylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole

5-(3-methoxy-4-methylphenyl)-3-(3-methyl-4-pyridinyl)-1,2,4-oxadiazole;5-(3-methoxy-4-methylphenyl)-3-(5-methyl-3-pyridinyl)-1,2,4-oxadiazole;4-[5-(3-methoxy-4-methylphenyl)-1,2,4-oxadiazol-3-yl]pyridin-2-amine;5-(3-methoxy-4-methylphenyl)-3-pyridin-3-yl-1,2,4-oxadiazole;3-(3-methyl-4-pyridinyl)-5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(5-methyl-3-pyridinyl)-5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;4-[5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]pyridin-2-amine;5-[4-methyl-3-(trifluoromethyl)phenyl]-3-pyridin-3-yl-1,2,4-oxadiazole;5-(4-octylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole (PubChem CID 157417571) has the molecular formula C145H127F12N29O13 and a molecular weight of 2711.78 g/mol. Its IUPAC name is 5-(3-methoxy-4-methylphenyl)-3-(3-methyl-4-pyridinyl)-1,2,4-oxadiazole;5-(3-methoxy-4-methylphenyl)-3-(5-methyl-3-pyridinyl)-1,2,4-oxadiazole;4-[5-(3-methoxy-4-methylphenyl)-1,2,4-oxadiazol-3-yl]pyridin-2-amine;5-(3-methoxy-4-methylphenyl)-3-pyridin-3-yl-1,2,4-oxadiazole;3-(3-methyl-4-pyridinyl)-5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(5-methyl-3-pyridinyl)-5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;4-[5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]pyridin-2-amine;5-[4-methyl-3-(trifluoromethyl)phenyl]-3-pyridin-3-yl-1,2,4-oxadiazole;5-(4-octylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole.

Molecular Properties

Compound Name5-(3-methoxy-4-methylphenyl)-3-(3-methyl-4-pyridinyl)-1,2,4-oxadiazole;5-(3-methoxy-4-methylphenyl)-3-(5-methyl-3-pyridinyl)-1,2,4-oxadiazole;4-[5-(3-methoxy-4-methylphenyl)-1,2,4-oxadiazol-3-yl]pyridin-2-amine;5-(3-methoxy-4-methylphenyl)-3-pyridin-3-yl-1,2,4-oxadiazole;3-(3-methyl-4-pyridinyl)-5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(5-methyl-3-pyridinyl)-5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;4-[5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]pyridin-2-amine;5-[4-methyl-3-(trifluoromethyl)phenyl]-3-pyridin-3-yl-1,2,4-oxadiazole;5-(4-octylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole
PubChem CID157417571
Molecular FormulaC145H127F12N29O13
Molecular Weight2711.78 g/mol
Exact Mass2710.00
IUPAC Name5-(3-methoxy-4-methylphenyl)-3-(3-methyl-4-pyridinyl)-1,2,4-oxadiazole;5-(3-methoxy-4-methylphenyl)-3-(5-methyl-3-pyridinyl)-1,2,4-oxadiazole;4-[5-(3-methoxy-4-methylphenyl)-1,2,4-oxadiazol-3-yl]pyridin-2-amine;5-(3-methoxy-4-methylphenyl)-3-pyridin-3-yl-1,2,4-oxadiazole;3-(3-methyl-4-pyridinyl)-5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(5-methyl-3-pyridinyl)-5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;4-[5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]pyridin-2-amine;5-[4-methyl-3-(trifluoromethyl)phenyl]-3-pyridin-3-yl-1,2,4-oxadiazole;5-(4-octylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole
SMILESCCCCCCCCc1ccc(-c2nc(-c3ccncc3)no2)cc1.COc1cc(-c2nc(-c3cccnc3)no2)ccc1C.COc1cc(-c2nc(-c3ccnc(N)c3)no2)ccc1C.COc1cc(-c2nc(-c3ccncc3C)no2)ccc1C.COc1cc(-c2nc(-c3cncc(C)c3)no2)ccc1C.Cc1ccc(-c2nc(-c3cccnc3)no2)cc1C(F)(F)F.Cc1ccc(-c2nc(-c3ccnc(N)c3)no2)cc1C(F)(F)F.Cc1cncc(-c2noc(-c3ccc(C)c(C(F)(F)F)c3)n2)c1.Cc1cnccc1-c1noc(-c2ccc(C)c(C(F)(F)F)c2)n1
InChIInChI=1S/C21H25N3O.2C16H12F3N3O.2C16H15N3O2.C15H11F3N4O.C15H10F3N3O.C15H14N4O2.C15H13N3O2/c1-2-3-4-5-6-7-8-17-9-11-19(12-10-17)21-23-20(24-25-21)18-13-15-22-16-14-18;1-9-5-12(8-20-7-9)14-21-15(23-22-14)11-4-3-10(2)13(6-11)16(17,18)19;1-9-3-4-11(7-13(9)16(17,18)19)15-21-14(22-23-15)12-5-6-20-8-10(12)2;1-10-6-13(9-17-8-10)15-18-16(21-19-15)12-5-4-11(2)14(7-12)20-3;1-10-4-5-12(8-14(10)20-3)16-18-15(19-21-16)13-6-7-17-9-11(13)2;1-8-2-3-10(6-11(8)15(16,17)18)14-21-13(22-23-14)9-4-5-20-12(19)7-9;1-9-4-5-10(7-12(9)15(16,17)18)14-20-13(21-22-14)11-3-2-6-19-8-11;1-9-3-4-11(7-12(9)20-2)15-18-14(19-21-15)10-5-6-17-13(16)8-10;1-10-5-6-11(8-13(10)19-2)15-17-14(18-20-15)12-4-3-7-16-9-12/h9-16H,2-8H2,1H3;2*3-8H,1-2H3;2*4-9H,1-3H3;2-7H,1H3,(H2,19,20);2-8H,1H3;3-8H,1-2H3,(H2,16,17);3-9H,1-2H3
InChIKeyBPAMBTMYSBCDIP-UHFFFAOYSA-N
XLogP35.07
TPSA555.25 Ų
H-Bond Donors2
H-Bond Acceptors42
Rotatable Bonds29
Heavy Atoms199
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002711.78
LogP ≤ 535.07
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1042

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 5-(3-methoxy-4-methylphenyl)-3-(3-methyl-4-pyridinyl)-1,2,4-oxadiazole;5-(3-methoxy-4-methylphenyl)-3-(5-methyl-3-pyridinyl)-1,2,4-oxadiazole;4-[5-(3-methoxy-4-methylphenyl)-1,2,4-oxadiazol-3-yl]pyridin-2-amine;5-(3-methoxy-4-methylphenyl)-3-pyridin-3-yl-1,2,4-oxadiazole;3-(3-methyl-4-pyridinyl)-5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(5-methyl-3-pyridinyl)-5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;4-[5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]pyridin-2-amine;5-[4-methyl-3-(trifluoromethyl)phenyl]-3-pyridin-3-yl-1,2,4-oxadiazole;5-(4-octylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-(3-methoxy-4-methylphenyl)-3-(3-methyl-4-pyridinyl)-1,2,4-oxadiazole;5-(3-methoxy-4-methylphenyl)-3-(5-methyl-3-pyridinyl)-1,2,4-oxadiazole;4-[5-(3-methoxy-4-methylphenyl)-1,2,4-oxadiazol-3-yl]pyridin-2-amine;5-(3-methoxy-4-methylphenyl)-3-pyridin-3-yl-1,2,4-oxadiazole;3-(3-methyl-4-pyridinyl)-5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(5-methyl-3-pyridinyl)-5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;4-[5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]pyridin-2-amine;5-[4-methyl-3-(trifluoromethyl)phenyl]-3-pyridin-3-yl-1,2,4-oxadiazole;5-(4-octylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole?
The IUPAC name of 5-(3-methoxy-4-methylphenyl)-3-(3-methyl-4-pyridinyl)-1,2,4-oxadiazole;5-(3-methoxy-4-methylphenyl)-3-(5-methyl-3-pyridinyl)-1,2,4-oxadiazole;4-[5-(3-methoxy-4-methylphenyl)-1,2,4-oxadiazol-3-yl]pyridin-2-amine;5-(3-methoxy-4-methylphenyl)-3-pyridin-3-yl-1,2,4-oxadiazole;3-(3-methyl-4-pyridinyl)-5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(5-methyl-3-pyridinyl)-5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;4-[5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]pyridin-2-amine;5-[4-methyl-3-(trifluoromethyl)phenyl]-3-pyridin-3-yl-1,2,4-oxadiazole;5-(4-octylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole (CID 157417571) is 5-(3-methoxy-4-methylphenyl)-3-(3-methyl-4-pyridinyl)-1,2,4-oxadiazole;5-(3-methoxy-4-methylphenyl)-3-(5-methyl-3-pyridinyl)-1,2,4-oxadiazole;4-[5-(3-methoxy-4-methylphenyl)-1,2,4-oxadiazol-3-yl]pyridin-2-amine;5-(3-methoxy-4-methylphenyl)-3-pyridin-3-yl-1,2,4-oxadiazole;3-(3-methyl-4-pyridinyl)-5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(5-methyl-3-pyridinyl)-5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;4-[5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]pyridin-2-amine;5-[4-methyl-3-(trifluoromethyl)phenyl]-3-pyridin-3-yl-1,2,4-oxadiazole;5-(4-octylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole.
What is the SMILES notation for 5-(3-methoxy-4-methylphenyl)-3-(3-methyl-4-pyridinyl)-1,2,4-oxadiazole;5-(3-methoxy-4-methylphenyl)-3-(5-methyl-3-pyridinyl)-1,2,4-oxadiazole;4-[5-(3-methoxy-4-methylphenyl)-1,2,4-oxadiazol-3-yl]pyridin-2-amine;5-(3-methoxy-4-methylphenyl)-3-pyridin-3-yl-1,2,4-oxadiazole;3-(3-methyl-4-pyridinyl)-5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(5-methyl-3-pyridinyl)-5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;4-[5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]pyridin-2-amine;5-[4-methyl-3-(trifluoromethyl)phenyl]-3-pyridin-3-yl-1,2,4-oxadiazole;5-(4-octylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole?
The canonical SMILES for 5-(3-methoxy-4-methylphenyl)-3-(3-methyl-4-pyridinyl)-1,2,4-oxadiazole;5-(3-methoxy-4-methylphenyl)-3-(5-methyl-3-pyridinyl)-1,2,4-oxadiazole;4-[5-(3-methoxy-4-methylphenyl)-1,2,4-oxadiazol-3-yl]pyridin-2-amine;5-(3-methoxy-4-methylphenyl)-3-pyridin-3-yl-1,2,4-oxadiazole;3-(3-methyl-4-pyridinyl)-5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(5-methyl-3-pyridinyl)-5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;4-[5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]pyridin-2-amine;5-[4-methyl-3-(trifluoromethyl)phenyl]-3-pyridin-3-yl-1,2,4-oxadiazole;5-(4-octylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole is CCCCCCCCc1ccc(-c2nc(-c3ccncc3)no2)cc1.COc1cc(-c2nc(-c3cccnc3)no2)ccc1C.COc1cc(-c2nc(-c3ccnc(N)c3)no2)ccc1C.COc1cc(-c2nc(-c3ccncc3C)no2)ccc1C.COc1cc(-c2nc(-c3cncc(C)c3)no2)ccc1C.Cc1ccc(-c2nc(-c3cccnc3)no2)cc1C(F)(F)F.Cc1ccc(-c2nc(-c3ccnc(N)c3)no2)cc1C(F)(F)F.Cc1cncc(-c2noc(-c3ccc(C)c(C(F)(F)F)c3)n2)c1.Cc1cnccc1-c1noc(-c2ccc(C)c(C(F)(F)F)c2)n1.
What is the InChIKey of 5-(3-methoxy-4-methylphenyl)-3-(3-methyl-4-pyridinyl)-1,2,4-oxadiazole;5-(3-methoxy-4-methylphenyl)-3-(5-methyl-3-pyridinyl)-1,2,4-oxadiazole;4-[5-(3-methoxy-4-methylphenyl)-1,2,4-oxadiazol-3-yl]pyridin-2-amine;5-(3-methoxy-4-methylphenyl)-3-pyridin-3-yl-1,2,4-oxadiazole;3-(3-methyl-4-pyridinyl)-5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(5-methyl-3-pyridinyl)-5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;4-[5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]pyridin-2-amine;5-[4-methyl-3-(trifluoromethyl)phenyl]-3-pyridin-3-yl-1,2,4-oxadiazole;5-(4-octylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole?
The InChIKey is BPAMBTMYSBCDIP-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H25N3O.2C16H12F3N3O.2C16H15N3O2.C15H11F3N4O.C15H10F3N3O.C15H14N4O2.C15H13N3O2/c1-2-3-4-5-6-7-8-17-9-11-19(12-10-17)21-23-20(24-25-21)18-13-15-22-16-14-18;1-9-5-12(8-20-7-9)14-21-15(23-22-14)11-4-3-10(2)13(6-11)16(17,18)19;1-9-3-4-11(7-13(9)16(17,18)19)15-21-14(22-23-15)12-5-6-20-8-10(12)2;1-10-6-13(9-17-8-10)15-18-16(21-19-15)12-5-4-11(2)14(7-12)20-3;1-10-4-5-12(8-14(10)20-3)16-18-15(19-21-16)13-6-7-17-9-11(13)2;1-8-2-3-10(6-11(8)15(16,17)18)14-21-13(22-23-14)9-4-5-20-12(19)7-9;1-9-4-5-10(7-12(9)15(16,17)18)14-20-13(21-22-14)11-3-2-6-19-8-11;1-9-3-4-11(7-12(9)20-2)15-18-14(19-21-15)10-5-6-17-13(16)8-10;1-10-5-6-11(8-13(10)19-2)15-17-14(18-20-15)12-4-3-7-16-9-12/h9-16H,2-8H2,1H3;2*3-8H,1-2H3;2*4-9H,1-3H3;2-7H,1H3,(H2,19,20);2-8H,1H3;3-8H,1-2H3,(H2,16,17);3-9H,1-2H3.
What are the key properties of 5-(3-methoxy-4-methylphenyl)-3-(3-methyl-4-pyridinyl)-1,2,4-oxadiazole;5-(3-methoxy-4-methylphenyl)-3-(5-methyl-3-pyridinyl)-1,2,4-oxadiazole;4-[5-(3-methoxy-4-methylphenyl)-1,2,4-oxadiazol-3-yl]pyridin-2-amine;5-(3-methoxy-4-methylphenyl)-3-pyridin-3-yl-1,2,4-oxadiazole;3-(3-methyl-4-pyridinyl)-5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(5-methyl-3-pyridinyl)-5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;4-[5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]pyridin-2-amine;5-[4-methyl-3-(trifluoromethyl)phenyl]-3-pyridin-3-yl-1,2,4-oxadiazole;5-(4-octylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole?
5-(3-methoxy-4-methylphenyl)-3-(3-methyl-4-pyridinyl)-1,2,4-oxadiazole;5-(3-methoxy-4-methylphenyl)-3-(5-methyl-3-pyridinyl)-1,2,4-oxadiazole;4-[5-(3-methoxy-4-methylphenyl)-1,2,4-oxadiazol-3-yl]pyridin-2-amine;5-(3-methoxy-4-methylphenyl)-3-pyridin-3-yl-1,2,4-oxadiazole;3-(3-methyl-4-pyridinyl)-5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(5-methyl-3-pyridinyl)-5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;4-[5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]pyridin-2-amine;5-[4-methyl-3-(trifluoromethyl)phenyl]-3-pyridin-3-yl-1,2,4-oxadiazole;5-(4-octylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole has a molecular weight of 2711.78 g/mol, XLogP of 35.07, 29 rotatable bonds, 2 hydrogen bond donors, and 42 hydrogen bond acceptors.
Where does this data come from?
All data for 5-(3-methoxy-4-methylphenyl)-3-(3-methyl-4-pyridinyl)-1,2,4-oxadiazole;5-(3-methoxy-4-methylphenyl)-3-(5-methyl-3-pyridinyl)-1,2,4-oxadiazole;4-[5-(3-methoxy-4-methylphenyl)-1,2,4-oxadiazol-3-yl]pyridin-2-amine;5-(3-methoxy-4-methylphenyl)-3-pyridin-3-yl-1,2,4-oxadiazole;3-(3-methyl-4-pyridinyl)-5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;3-(5-methyl-3-pyridinyl)-5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole;4-[5-[4-methyl-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-3-yl]pyridin-2-amine;5-[4-methyl-3-(trifluoromethyl)phenyl]-3-pyridin-3-yl-1,2,4-oxadiazole;5-(4-octylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole is sourced from PubChem (CID 157417571), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).